These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16970156)

  • 21. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
    Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
    Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadherin switching in human prostate cancer progression.
    Tomita K; van Bokhoven A; van Leenders GJ; Ruijter ET; Jansen CF; Bussemakers MJ; Schalken JA
    Cancer Res; 2000 Jul; 60(13):3650-4. PubMed ID: 10910081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.
    Janda E; Nevolo M; Lehmann K; Downward J; Beug H; Grieco M
    Oncogene; 2006 Nov; 25(54):7117-30. PubMed ID: 16751808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
    Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
    Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
    Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
    Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials].
    Zhang LL; He DL; Li X; Li L; Zhu GD; Wang XY
    Zhonghua Nan Ke Xue; 2006 Oct; 12(10):913-6. PubMed ID: 17121023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
    Kolijn K; Verhoef EI; van Leenders GJ
    Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
    Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Over-expression of Hypoxia-inducible factor 1alpha increases invasive potency of LNCaP cells in vitro].
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2285-8. PubMed ID: 17064578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
    Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
    Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.
    Whitbread AK; Veveris-Lowe TL; Lawrence MG; Nicol DL; Clements JA
    Biol Chem; 2006 Jun; 387(6):707-14. PubMed ID: 16800731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis.
    Liao J; Schneider A; Datta NS; McCauley LK
    Cancer Res; 2006 Sep; 66(18):9065-73. PubMed ID: 16982748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
    Ramos DM; Dang D; Sadler S
    Anticancer Res; 2009 Jan; 29(1):125-30. PubMed ID: 19331141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells.
    Nalla AK; Estes N; Patel J; Rao JS
    Exp Cell Res; 2011 Oct; 317(17):2512-21. PubMed ID: 21855541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of LMO2 expression in the progression of prostate cancer.
    Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
    J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.